Detalles de la búsqueda
1.
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
Antimicrob Agents Chemother
; 68(4): e0156223, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376228
2.
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
Antimicrob Agents Chemother
; 67(4): e0003523, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920217
3.
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
Antimicrob Agents Chemother
; 66(4): e0239821, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315690
4.
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Antimicrob Agents Chemother
; 66(6): e0013222, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35607978
5.
Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer.
Antimicrob Agents Chemother
; 65(11): e0141821, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460302
6.
Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 65(12): e0141221, 2021 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570644
7.
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33526488
8.
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis.
Antimicrob Agents Chemother
; 65(7): e0025321, 2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903099
9.
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32205344
10.
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036687
11.
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559131
12.
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833432
13.
High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30455239
14.
Advancing the Therapeutic Potential of Indoleamides for Tuberculosis.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010860
15.
Mutations in Rv0678 Reduce Susceptibility of Mycobacterium tuberculosis to the DprE1 Inhibitor TBA-7371.
Antimicrob Agents Chemother
; 67(3): e0005223, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36786606
16.
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
Proc Natl Acad Sci U S A
; 112(3): 869-74, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25561537
17.
Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28874368
18.
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28630203
19.
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 60(1): 270-7, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503656
20.
Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.
Antimicrob Agents Chemother
; 59(7): 4026-30, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25918146